The Israeli life sciences patent litigation market is dominated by Tal Band and Liad Whatstein of S Horowitz & Co and Dr Shlomo Cohen & Co respectively. Band and his team of assistants are kept busy representing Teva, the largest generic pharmaceuticals company in the world, which is headquartered in Israel. Whatstein is usually on the other side, as he works exclusively with innovator companies. The relatively limited amount of remaining work, including smaller cases involving Teva, goes to generalist IP and litigation attorneys at other firms.
Tal Band has built up a significant team at S Horowitz & Co. He continues to spend the vast majority of his own time on life sciences patent litigation cases, most often for key generic-side client Teva; he is regarded as an “extremely knowledgeable and skilful” attorney. Band often locks horns with his innovator-focused counterpart, Liad Whatstein of Dr Shlomo Cohen & Co. Whatstein’s clients include Merck, Abbott, Johnson & Johnson and Schering- Plough. He recently won a victory as lead counsel for Sanofi in a complex trial involving its drug Allegra, which concluded with Teva admitting infringement and validity. Clients describe him as a “hard worker who can provide valuable strategic advice beyond the patent litigation issues”.
Eran Bareket is a general patent litigator at Gilat, Bareket & Co, Reinhold Cohn Group, with strong expertise in life sciences cases. At the same firm, David Gilat also devotes a significant portion of his patent litigation practice to life sciences matters and is “a good choice”, according to referring lawyers from outside Israel. Richard Luthi of Luthi & Co is a highly respected litigator. Eitan Shaulsky is at Sanford T Colb & Co and is considered “a good lawyer” by his peers. Ran Vogel of S Horowitz & Co is a familiar presence in the field and often assists Tal Band on complex cases for Teva.